149 related articles for article (PubMed ID: 33960231)
1. Up-regulation of KLF17 expression increases the sensitivity of gastric cancer to 5-fluorouracil.
An ZJ; Li Y; Tan BB; Zhao Q; Fan LQ; Zhang ZD; Zhao XF; Li SY
Int J Immunopathol Pharmacol; 2021; 35():20587384211010925. PubMed ID: 33960231
[TBL] [Abstract][Full Text] [Related]
2. GALNT10 promotes the proliferation and metastatic ability of gastric cancer and reduces 5-fluorouracil sensitivity by activating HOXD13.
Xu G; Wu YL; Li N; Xu R; Zhang JB; Ming H; Zhang Y
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11610-11619. PubMed ID: 33275228
[TBL] [Abstract][Full Text] [Related]
3. Effect of
Li S; Li Y; Tan B; An Z
J Int Med Res; 2021 Nov; 49(11):3000605211051581. PubMed ID: 34738482
[TBL] [Abstract][Full Text] [Related]
4. Cardamonin, a natural chalcone, reduces 5-fluorouracil resistance of gastric cancer cells through targeting Wnt/β-catenin signal pathway.
Hou G; Yuan X; Li Y; Hou G; Liu X
Invest New Drugs; 2020 Apr; 38(2):329-339. PubMed ID: 31102118
[TBL] [Abstract][Full Text] [Related]
5. Enhanced RegIV expression predicts the intrinsic 5-fluorouracil (5-FU) resistance in advanced gastric cancer.
Ying LS; Yu JL; Lu XX; Ling ZQ
Dig Dis Sci; 2013 Feb; 58(2):414-22. PubMed ID: 23010741
[TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
[TBL] [Abstract][Full Text] [Related]
7. Reduced Krüppel-like factor 17 (KLF17) expression correlates with poor survival in patients with gastric cancer.
Peng JJ; Wu B; Xiao XB; Shao YS; Feng Y; Yin MX
Arch Med Res; 2014 Jul; 45(5):394-9. PubMed ID: 24947617
[TBL] [Abstract][Full Text] [Related]
8. Precision hyperthermia-induced miRNA-409-3p upregulation inhibits migration, invasion, and EMT of gastric cancer cells by targeting KLF17.
Feng J; Li K; Liu G; Feng Y; Shi H; Zhang X
Biochem Biophys Res Commun; 2021 Apr; 549():113-119. PubMed ID: 33667708
[TBL] [Abstract][Full Text] [Related]
9. Autophagy Facilitates Metadherin-Induced Chemotherapy Resistance Through the AMPK/ATG5 Pathway in Gastric Cancer.
Pei G; Luo M; Ni X; Wu J; Wang S; Ma Y; Yu J
Cell Physiol Biochem; 2018; 46(2):847-859. PubMed ID: 29635244
[TBL] [Abstract][Full Text] [Related]
10. Regulatory mechanism of ZNF139 in multi-drug resistance of gastric cancer cells.
Li Y; Tan BB; Zhao Q; Fan LQ; Liu Y; Wang D
Mol Biol Rep; 2014 Jun; 41(6):3603-10. PubMed ID: 24515389
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.
Gong Y; Ren J; Liu K; Tang LM
World J Gastroenterol; 2015 Mar; 21(10):2949-58. PubMed ID: 25780292
[TBL] [Abstract][Full Text] [Related]
12. Combination of NRP1-mediated iRGD with 5-fluorouracil suppresses proliferation, migration and invasion of gastric cancer cells.
Zhang L; Xing Y; Gao Q; Sun X; Zhang D; Cao G
Biomed Pharmacother; 2017 Sep; 93():1136-1143. PubMed ID: 28738522
[TBL] [Abstract][Full Text] [Related]
13. Trim14 promotes autophagy and chemotherapy resistance of gastric cancer cells by regulating AMPK/mTOR pathway.
Xiao F; Ouyang B; Zou J; Yang Y; Yi L; Yan H
Drug Dev Res; 2020 Aug; 81(5):544-550. PubMed ID: 32096264
[TBL] [Abstract][Full Text] [Related]
14. Rosmarinic acid reduces the resistance of gastric carcinoma cells to 5-fluorouracil by downregulating FOXO4-targeting miR-6785-5p.
Yu C; Chen DQ; Liu HX; Li WB; Lu JW; Feng JF
Biomed Pharmacother; 2019 Jan; 109():2327-2334. PubMed ID: 30551491
[TBL] [Abstract][Full Text] [Related]
15. DCTPP1 attenuates the sensitivity of human gastric cancer cells to 5-fluorouracil by up-regulating MDR1 expression epigenetically.
Xia LL; Tang YB; Song FF; Xu L; Ji P; Wang SJ; Zhu JM; Zhang Y; Zhao GP; Wang Y; Liu TT
Oncotarget; 2016 Oct; 7(42):68623-68637. PubMed ID: 27612427
[TBL] [Abstract][Full Text] [Related]
16. 5-Fluorouracil chemotherapy of gastric cancer generates residual cells with properties of cancer stem cells.
Xu ZY; Tang JN; Xie HX; Du YA; Huang L; Yu PF; Cheng XD
Int J Biol Sci; 2015; 11(3):284-94. PubMed ID: 25678847
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between CD133 and chemoresistance in human gastric cancer and its associated mechanism].
Zhu Y; Jiang B; Cai C; Wang S; Wu J; Yu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Feb; 17(2):168-74. PubMed ID: 24577774
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Proliferation and Epithelial-to-Mesenchymal Transition (EMT) of Gastric Cancer by ZEB1 via Modulating Wnt5a and Related Mechanisms.
Xue Y; Zhang L; Zhu Y; Ke X; Wang Q; Min H
Med Sci Monit; 2019 Mar; 25():1663-1670. PubMed ID: 30829316
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of cellular repressor of E1A-stimulated gene (CREG) in gastric cancer patients: a mechanism of proliferation and metastasis in cancer.
Xu L; Wang F; Liu H; Xu XF; Mo WH; Xia YJ; Wan R; Wang XP; Guo CY
Dig Dis Sci; 2011 Jun; 56(6):1645-55. PubMed ID: 21132365
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 overexpression predicts prognosis and 5-FU resistance in gastric cancer.
Hu XF; Yao J; Gao SG; Wang XS; Peng XQ; Yang YT; Feng XS
Asian Pac J Cancer Prev; 2013; 14(9):5231-5. PubMed ID: 24175806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
